Silencing MED1 Sensitizes Breast Cancer Cells to Pure Anti-Estrogen Fulvestrant In Vitro and In Vivo

Pure anti-estrogen fulvestrant has been shown to be a promising ER antagonist for locally advanced and metastatic breast cancer. Unfortunately, a significant proportion of patients developed resistance to this type of endocrine therapy but the molecular mechanisms governing cellular responsiveness t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lijiang, Cui, Jiajun, Leonard, Marissa, Nephew, Kenneth, Li, Yongquan, Zhang, Xiaoting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728322/
https://www.ncbi.nlm.nih.gov/pubmed/23936234
http://dx.doi.org/10.1371/journal.pone.0070641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728322/
https://www.ncbi.nlm.nih.gov/pubmed/23936234
http://dx.doi.org/10.1371/journal.pone.0070641

Ejemplares similares